Arbor Rapha Capital Bioho... (ARCKU)
NASDAQ: ARCKU
· Real-Time Price · USD
12.00
0.00 (0.00%)
At close: Jan 12, 2023, 7:05 PM
Company Description
Arbor Rapha Capital Bioholdings Corp.
I does not have significant operations.
The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses.
It intends to identify acquisition opportunities in the biopharmaceutical sector.
The company was incorporated in 2021 and is based in Uniondale, New York.
Arbor Rapha Capital Bioholdings Corp. I
| Country | United States |
| IPO Date | n/a |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Ivan Paul Kaufman |
Contact Details
Address: 333 Earle Ovington Blvd Uniondale, New York United States | |
| Website | https://www.arcbiocorp.com |
Stock Details
| Ticker Symbol | ARCKU |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001855886 |
| CUSIP Number | 03881F203 |
| ISIN Number | n/a |
| Employer ID | 86-2427174 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Ivan Paul Kaufman | Chairman, Chief Executive Officer & Pres |
| Paul Anthony Elenio | Chief Financial Officer |
| Dr. Kevin M. Slawin M.D. | Chief Strategy Officer & Director |
| John Natalone CPA | Treasurer |
| William P. Connolly | Vice President & Sec. |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 13, 2023 | 15-12G | Filing |
| Mar 07, 2023 | 8-K | Current Report |
| Mar 03, 2023 | 25-NSE | Filing |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 10, 2023 | DEF 14A | Filing |
| Feb 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 30, 2023 | PRE 14A | Filing |
| Jan 18, 2023 | 8-K | Current Report |
| Dec 09, 2022 | 8-K | Current Report |